D-0124-2018 Class III Terminated

Recalled by Renaissance Lakewood, LLC — Lakewood, NJ

FDA drug recall D-0124-2018 was initiated by Renaissance Lakewood, LLC on Nov 11, 2017 and is designated Class III. Reason for recall: Superpotent The recall status is terminated (terminated Apr 1, 2020). Affected quantity: 24,569 bags.

Recall details

Product Type
Drugs
Report Date
Dec 27, 2017
Initiation Date
Nov 11, 2017
Termination Date
Apr 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24,569 bags

Product description

Fluconazole Injection, USP, 2 mg/mL, a) 50 mL (NDC 336000-261-10) and b) 100 mL (NDC 33600-002-10), Rx Only, Manufactured for: Claris LifeSciences, Inc. North Brunswick, NJ 08902 By: Claris Injectables Ltd., Gujarat, India

Reason for recall

Superpotent

Distribution pattern

Nationwide

Code information

a) A060174 01/13/2018, A060257 02/28/2018, A060692 05/31/2018, A061165 09/30/2018, A0A0143 01/31/2019, A0A0347 03/31/2019, and A0A0424 04/30/2019 ; b) A060027 12/31/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0124-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0124-2018. Report a data issue: hello@regdatalab.com.